Treatment of conjunctival squamous neoplasias with interferon alpha 2b

Journal Francais d'Ophtalmologie

Volumn 31, Issue 3, 2008, Pages 317-325

  Huerva, V ^a   Mangues, I ^a  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

CIN; Conjunctival intraepithelial neoplasia; Conjunctival squamous neoplasia; Interferon alpha 2b

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; FLUOROURACIL; MITOMYCIN;

CONJUNCTIVA TUMOR; HUMAN; REVIEW; SQUAMOUS CELL CARCINOMA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CONJUNCTIVAL NEOPLASMS; FLUOROURACIL; HUMANS; INTERFERON ALFA-2B; MITOMYCIN;

EID: 42149126680     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0181-5512(08)74813-7     Document Type: Review

References (51)

1. Grossniklaus HE, Green WR, Luckenbach M, Chan CC. Conjunctival lesions in adults. A clinical and histopathologic review. Cornea, 1987;6:78-116.
2. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol, 1995;39:429-50.
3. Erie JC, Campbell RJ, Leisegang TJ. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology, 1986;93:176-83.
4. Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol, 2004;49:3-24.
5. Scott IU, Karp CL, Nuovo GJ. Human papillomavirus 16 and 13 expresion in conjunctival intraepithelial neoplasia. Ophthalmology, 2002;109:542-7.
6. Huerva V, Mateo AJ, Mangues I, Jurjo C. Short-term mitomycin C followed by long-term interferon alpha 2β for conjunctiva-cornea intraepithelial neoplasia. Cornea, 2006;25:1220-3.
7. Lass JH, Foster CS, Grove AS, et al. Interferon alpha therapy of recurrent conjunctival papillomas. Am J Ophthalmol, 1987;103:294-301.
8. Parulekar MV, Khooshabeh R, Graham C. Topical and intralesional interferon therapy for recurrent lacrimal papilloma. Eye, 2002;16:649-51.
9. Falco LA, Gruosso PJ, Skolnick K, Bejar L. Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma. Optometry, 2007;78:162-6.
10. Di Pascuale MA, Espana E, Tseng SCG. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Cornea, 2004;23:89-92.
11. Giaconi JA, Karp CL. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocul Surf, 2003;1:66-73.
12. Chen C, Louis D, Dodd T, Muecke J. Mytomicin C as an adjunct in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol, 2004;88:17-8.
13. Frutch-Pery J, Rozenman Y, Péer J. Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma. Ophthalmology, 2002;109:548-52.
14. Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol, 2002;133:601-6.
15. Shields CL, Demirci H, Marr BP, et al. Chemoreduction with topical Mytomycin C prior to resection of extensive squamous cell carcinoma of the conjuntiva. Arch Ophthalmol, 2005;123:109-13.
16. Poothullil AM, Colby KA. Topical medical therapies for ocular surface tumors. Seminars Ophthalmol, 2006;21:161-9.
17. Guthoff R, Lieb WE, Ströbel P, Zettl A. Exenteration of invasive conjunctival squamous cell carcinoma. Br J Ophthalmol, 2004;88:1093-4.
18. Wilson MW, Hungerford JL, George SM, Madreperla SA. Topical Mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol, 1997;124:303-11.
19. Frucht-Pery J, Rozenmam Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol, 1994;117:164-8.
20. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctivalcorneal intraepithelial neoplasia: a multicenter experience. Ophthalmology, 1997;104:2085-93.
21. Khong JJ, Muecke J. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol, 2006;90:819-22.
22. Dogru M, Erturk H, Shimazaki J, Tsubota K, Gul M. Tear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraephitelial neoplasia. Cornea, 2003;22:627-39.
23. Dudney BW, Malecha MA. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraephitelial neoplasia. Am J Ophthalmol, 2004;137:950-1.
24. Chang SW. Early corneal edema following topical application of mitomycin-C. J Cataract Refract Surg, 2004;30:1742-50.
25. Smith M, Trousdale MD, Rao NA, Robin JB. Lack of toxicity of a topical recombinant interferon. Cornea, 1989;8:58-61.
26. Huerva V, Sánchez MC, Mangues I. Tumor volume increase at beginning of primary treatment with topical interferon alpha 2b in a case of conjunctivacornea intraepithelial neoplasia. J Ocul Pharmacol Ther, 2007;23:143-5.
27. Schechter BA, Schrier A, Nagler RS, Smith EF, Velasquez GE. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea, 2002;21:6-11.
28. Boehm MD, Huang AJ. Treatment of recurrent corneal and conjuntival intraepithelial neoplasia with topical interferon alfa 2 b. Ophthalmology, 2004;111:1755-61.
29. Nemet AY, Sharma V, Benger R. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to escisión, cryotherapy and mitomycin-C. Clin Exp Ophthalmol, 2006;34:375-7.
30. Kobayashi A, Yoshita T, Uchiyama K, Shirao Y, Kitagawa K, Fujisawa A, Tseng SC. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b. Jpn J Ophthalmol, 2002;46:215-7.
31. Hu FR, Wu MJ, Kuo SH. Interferon treatment for corneolimbal squamous dysplasia. Am J Ophthalmol, 1998;125:118-9.
32. Vann RR, Karp CL. Perilesional and topical interferon alfa 2b for conjuntival and corneal neoplasia. Ophthalmology, 1999;106:91-7.
33. Esquenazi S, Fry CL, Holley E. Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b. Br J Ophthalmol, 2005;89:1221.
34. Morgenstern KE, Givan J, Wiley LA. Long-term adminstration of topical interferon alfa-2b in the treatment of conjunctival squamous papilloma. Arch Ophthalmol, 2003;121:1052-3.
35. Maskin SL. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol, 1994;112:1145-6.
36. Karp CL, Moor JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interpferon alpha-2b. Ophthalmology, 2001;108:1093-8.
37. Toledano-Fenandez N, Garcia-Saenz S, Díaz-Valle D, et al. Interferon alfa-2b treatment in selected cases of recurrent conjunctival intraepithelial neoplasia. Arch Soc Esp Oftalmol, 2003;78:265-71.
38. Fuchsluger TA, Hintschich C, Steuhl KP, Meller D. Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface. Ophthalmologe, 2006;103:124-8.
39. Schechter BA. Conjunctival intraepithelial neoplasia. Ophthalmology, 1999;106:1642-3.
40. Díaz-Valle D, Benitez del Castillo JM, Diaz-Valle T, Poza-Morales Y, Arteaga-Sánchez A. Treatment with topical interferon alone in severe conjunctivo-corneal neoplasia. Arch Soc Esp Oftalmol, 2005;80:729-32.
41. Hawkins AS, Yu J, Hamming NA, Rubenstein JB. Treatment of recurrent conjunctival papillomatosis with mytomycin C. Am J Ophthalmol, 1999;128:638-40.
42. Chen HC, Chang SW, Huang SF. Adjunctive treatment with interferon alpha-2b may decrease the risk of papilloma-associated conjunctival intraepithelial neoplasm recurrence. Cornea, 2004;23:726-9.
43. De Keizer RJW, de Wolff-Rouendaal D. Topical interferon in recurrent conjunctival papilloma. Acta Ophthalmol Scand, 2003;81:193-6.
44. Schechter BA, Rand WJ, Velazquez GE, Williams WD, Starasoler L. Treatment of conjunctival papillomata with topical interferon alfa-2b. Am J Ophthalmol, 2002;34:268-70.
45. Holcombe DJ, Lee GA. Topical interferon alfa-2 b for treatment of recalcitrant ocular surface squamous neoplasia. Am J Ophthalmol, 2006;142:568.e1-568.e6.
46. Mcevoy GK. Drug Information. American Society of Health-System Pharmacists. Bethesda, 2005.
47. Drugdex® System. Drug evaluations. Micromedex® Health care Series 2007.
48. Intron A. Summary of product characteristics: http://www.emea.eu.int/ humandocs/PDFs/EPAR/Introna/H-281-PI-en.pdf
49. Tabin G, Levin S, Snibson G, Loughnan M, Taylor H. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology, 1997;104:485-92.
50. Schechter BA, Nagler RS, Schrier A. Recurrent intraepithelial neoplasia treatment. Ophthalmology, 2005;112:1319.
51. Stone DU, Butt AL, Chodosh J. Ocular surface squamous neoplasia. Cornea, 2005;24:297-300.